mTORC1-dependent translational control of Cand2 leads to transcriptional reprogramming in diseased cardiac myocytes
Agnieszka Górska(Heidelberg University), Mirko Völkers(Heidelberg University), Christoph P. Hofmann(Heidelberg University), Verena Kamuf‐Schenk(Heidelberg University), Jennifer Furkel(Heidelberg University), Ellen Malovrh(Heidelberg University), Hugo A. Katus(Heidelberg University), Etienne Boileau(Heidelberg University), Claudia Stroh(Heidelberg University), Carsten Sticht(Heidelberg University), Vivien Kmietczyk(Heidelberg University), Eshita Varma(Heidelberg University), Matthias Konstandin(Heidelberg University), Christoph Dieterich(Heidelberg University), Clara Sandmann(Heidelberg University), Eva Riechert(Heidelberg University), Lonny Jürgensen(Heidelberg University), Norbert Frey(Heidelberg University)
Cited by 0
Related Papers
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease
|European Heart Journal|2020|1.8k
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2020|1.2k
European Society of Cardiology: cardiovascular disease statistics 2021
|European Heart Journal|2021|1.1k
Myocardial infarction accelerates atherosclerosis
|Nature|2012|1.1k